Document Detail


Anti-alcohol medication and pregnancy: weighing the risks.
MedLine Citation:
PMID:  22413725     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
When there is a major risk of alcohol withdrawal symptoms in a pregnant woman, a 7-day course of benzodiazepine therapy has a positive harm-benefit balance. Medications designed to help maintain abstinence are not sufficiently effective to warrant initiating treatment during pregnancy.
Authors:
-
Related Documents :
12408635 - Tributyltin and triphenyltin induce spermatogenesis in ovary of female abalone, halioti...
19111675 - Targeted disruption of the mouse lipoma preferred partner gene.
4056295 - Ectoparasitic infestation of the lashes.
7535255 - Identification, characterisation, and measurement of immunoglobulin concentrations in g...
22439075 - Antiphospholipid syndrome during pregnancy: the state of the art.
14981395 - Genetic influence on prolonged gestation: a population-based danish twin study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prescrire international     Volume:  21     ISSN:  1167-7422     ISO Abbreviation:  Prescrire Int     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9439295     Medline TA:  Prescrire Int     Country:  France    
Other Details:
Languages:  eng     Pagination:  48     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pregnancy: another opportunity to raise the issue of alcohol.
Next Document:  Learning from errors: a workshop for personal and collective reflection.